https://www.grunenthal.com/en/press-room/press-releases/2019/pr-gruenenthal-mesoblast-enter-strategic-partnership-innovative-cell-therapy-chronic-low-back-pain#:~:text=Under%20the%20partnership%2C%20Gr%C3%BCnenthal%20will,as%20further%20commercialisation%20milestone%20payments.
Is the confirmatory Ph III CLBP trial going to include European sites? I can’t recall seeing anything mentioned by the company (but vaguely remember, perhaps from way back, that the confirmatory might have European involvement), but they could receive a milestone payment from Grunenthal on the commencement of such, according to this. I’m not sure if this is the original announcement or the latest, post re-negotiation.
Does anyone know? Is it not a priority atm?
- Forums
- ASX - By Stock
- MSB
- banter and General Discussion
banter and General Discussion, page-10005
-
-
- There are more pages in this discussion • 355 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.14 |
Change
0.035(3.17%) |
Mkt cap ! $1.295B |
Open | High | Low | Value | Volume |
$1.08 | $1.15 | $1.08 | $3.223M | 2.903M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
39 | 31006 | $1.14 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.15 | 383916 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
38 | 48517 | 1.140 |
20 | 80067 | 1.135 |
16 | 141878 | 1.130 |
14 | 193645 | 1.125 |
12 | 145722 | 1.120 |
Price($) | Vol. | No. |
---|---|---|
1.145 | 342083 | 14 |
1.150 | 208012 | 22 |
1.155 | 112847 | 12 |
1.160 | 34360 | 7 |
1.165 | 17418 | 1 |
Last trade - 15.12pm 19/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |